View Curricumum Vitae »
|May. 2009 - Aug. 2013||Ph.D. in Clinical and Experimental Therapeutics, University of Southern California|
|Aug. 2005 - May 2009||Pharm.D., University of Southern California|
Dr. Yamaki’s research focuses on Methicillin-Resistant Staphylococcus aureus (MRSA) virulence, resistance, molecular epidemiology, patient outcomes, and host response to infection. His research has explored the contribution of highly virulent Community Associated-MRSA strains in patient infections, exotoxin production by these strains, and modulatory effects by sub-inhibitory antibiotics on exotoxin production. Exotoxin contribution to disease and modulatory effects of antibiotics are tested in both in-vitro cell culture and murine models of infection. Aside from designing and performing laboratory experiments he has been involved in designing and conducting a number of clinical studies. While Dr. Yamaki’s research has focused on MRSA, investigations into other highly drug resistant and virulent bacteria are planned in the near future.